This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Entenza, J. M.
Right arrow Articles by Moreillon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Entenza, J. M.
Right arrow Articles by Moreillon, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 07 1995, 1419-1424, Vol 39, No. 7
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500

JM Entenza, H Drugeon, MP Glauser and P Moreillon
Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

RP 59500 is a new injectable streptogramin composed of two synergistic components (quinupristin and dalfopristin) which are active against erythromycin-susceptible and -resistant gram-positive pathogens. The present experiments compared the therapeutic efficacy of RP 59500 with that of vancomycin against experimental endocarditis due to either of two erythromycin-susceptible or two constitutively erythromycin- resistant isolates of methicillin-resistant Staphylococcus aureus. RP 59500 had low MICs for the four test organisms as well as for 24 additional isolates (the MIC at which 90% of the isolates were inhibited was < 1 mg/liter) which were mostly inducibly (47%) or constitutively (39%) erythromycin resistant. Aortic endocarditis in rats was produced with catheter-induced vegetations. Three-day therapy was initiated 12 h after infection, and the drugs were delivered via a computerized pump, which permitted the mimicking of the drug kinetics produced in human serum by twice-daily intravenous injections of 7 mg of RP 59500 per kg of body weight or 1 g of vancomycin. Both antibiotics reduced vegetation bacterial titers to below detection levels in ca. 70% of animals infected with the erythromycin-susceptible isolates (P < 0.05 compared with titers in controls). Vancomycin was also effective against the constitutively resistant strains, but RP 59500 failed against these isolates. Further experiments proved that RP 59500 failures were related to the very short life span of dalfopristin in serum (< or = 2 h, compared with > or = 6 h for quinupristin), since successful treatment was restored by artificially prolonging the dalfopristin levels for 6 h.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:

  • Entenza, J. M., Haldimann, A., Giddey, M., Lociuro, S., Hawser, S., Moreillon, P. (2009). Efficacy of Iclaprim against Wild-Type and Thymidine Kinase-Deficient Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Fibrin Clot Model. Antimicrob. Agents Chemother. 53: 3635-3641 [Abstract] [Full Text]  
  • Kim, H. B., Jang, H.-C., Nam, H. J., Lee, Y. S., Kim, B. S., Park, W. B., Lee, K. D., Choi, Y. J., Park, S. W., Oh, M.-d., Kim, E.-C., Choe, K. W. (2004). In Vitro Activities of 28 Antimicrobial Agents against Staphylococcus aureus Isolates from Tertiary-Care Hospitals in Korea: a Nationwide Survey. Antimicrob. Agents Chemother. 48: 1124-1127 [Abstract] [Full Text]  
  • Cha, R., Brown, W. J., Rybak, M. J. (2003). Bactericidal Activities of Daptomycin, Quinupristin-Dalfopristin, and Linezolid against Vancomycin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations. Antimicrob. Agents Chemother. 47: 3960-3963 [Abstract] [Full Text]  
  • Allen, G. P., Cha, R., Rybak, M. J. (2002). In Vitro Activities of Quinupristin-Dalfopristin and Cefepime, Alone and in Combination with Various Antimicrobials, against Multidrug-Resistant Staphylococci and Enterococci in an In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother. 46: 2606-2612 [Abstract] [Full Text]  
  • Batard, E., Jacqueline, C., Boutoille, D., Hamel, A., Drugeon, H. B., Asseray, N., Leclercq, R., Caillon, J., Potel, G., Bugnon, D. (2002). Combination of Quinupristin-Dalfopristin and Gentamicin against Methicillin-Resistant Staphylococcus aureus: Experimental Rabbit Endocarditis Study. Antimicrob. Agents Chemother. 46: 2174-2178 [Abstract] [Full Text]  
  • Saleh-Mghir, A., Ameur, N., Muller-Serieys, C., Ismael, F., Lemaitre, F., Massias, L., Feger, C., Bleton, R., Cremieux, A.-C. (2002). Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin Is Highly Synergistic in Experimental Staphylococcus aureus Joint Prosthesis Infection. Antimicrob. Agents Chemother. 46: 1122-1124 [Abstract] [Full Text]  
  • Fuchs, P. C., Barry, A. L., Brown, S. D. (2001). Interactions of Quinupristin-Dalfopristin with Eight Other Antibiotics as Measured by Time-Kill Studies with 10 Strains of Staphylococcus aureus for Which Quinupristin-Dalfopristin Alone Was Not Bactericidal. Antimicrob. Agents Chemother. 45: 2662-2665 [Abstract] [Full Text]  
  • Zarrouk, V., Bozdogan, B., Leclercq, R., Garry, L., Feger, C., Carbon, C., Fantin, B. (2001). Activities of the Combination of Quinupristin-Dalfopristin with Rifampin In Vitro and in Experimental Endocarditis Due to Staphylococcus aureus Strains with Various Phenotypes of Resistance to Macrolide-Lincosamide-Streptogramin Antibiotics. Antimicrob. Agents Chemother. 45: 1244-1248 [Abstract] [Full Text]  
  • Boucher, H. W., Thauvin-Eliopoulos, C., Loebenberg, D., Eliopoulos, G. M. (2001). In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis. Antimicrob. Agents Chemother. 45: 208-211 [Abstract] [Full Text]  
  • Murphy, T. M., Deitz, J. M., Petersen, P. J., Mikels, S. M., Weiss, W. J. (2000). Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental Endocarditis. Antimicrob. Agents Chemother. 44: 3022-3027 [Abstract] [Full Text]  
  • Vouillamoz, J., Entenza, J. M., Féger, C., Glauser, M. P., Moreillon, P. (2000). Quinupristin-Dalfopristin Combined with beta -Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics. Antimicrob. Agents Chemother. 44: 1789-1795 [Abstract] [Full Text]  
  • Zarrouk, V., Bozdogan, B., Leclercq, R., Garry, L., Carbon, C., Fantin, B. (2000). Influence of Resistance to Streptogramin A Type Antibiotics on the Activity of Quinupristin-Dalfopristin In Vitro and in Experimental Endocarditis Due to Staphylococcus aureus. Antimicrob. Agents Chemother. 44: 1168-1173 [Abstract] [Full Text]  
  • Schmitz, F.-J., Verhoef, J., Fluit, A. C., The Sentry Participants Group, (1999). Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. J Antimicrob Chemother 43: 783-792 [Abstract] [Full Text]  
  • Trostdorf, F., Reinert, R. R., Schmidt, H., Nichterlein, T., Stuertz, K., Schmitz-Salue, M., Sadowski, I., Bruck, W., Nau, R. (1999). Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis. J Antimicrob Chemother 43: 87-94 [Abstract] [Full Text]  
  • Aeschlimann, J. R., Zervos, M. J., Rybak, M. J. (1998). Treatment of Vancomycin-Resistant Enterococcus faecium with RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations. Antimicrob. Agents Chemother. 42: 2710-2717 [Abstract] [Full Text]  
  • Aeschlimann, J. R., Rybak, M. J. (1998). Pharmacodynamic Analysis of the Activity of Quinupristin-Dalfopristin against Vancomycin-Resistant Enterococcus faecium with Differing MBCs via Time-Kill-Curve and Postantibiotic Effect Methods. Antimicrob. Agents Chemother. 42: 2188-2192 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»